GlassScriptPhysician profile
Thalia Attinger
NPI 1982137444
$738.08
in general payments reported to CMS, 2019-2025
9 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $97.65 · 2023: $219 · 2024: $215 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $433.88 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $166.75 | 2021-2025 | Grafix Pl, Stravix Pl |
| Hydrofera LLC | $28.84 | 2023-2024 | Hydrofera Blue |
| Solventum Corporation | $23.01 | 2025 | Prevena |
| Paratek Pharmaceuticals, INC. | $21.95 | 2025 | Nuzyra |
| Averitas Pharma INC. | $17.96 | 2023 | Qutenza |
| Cashflow Solutions, LLC | $15.87 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Ets Wound Care LLC | $15.25 | 2025 | Mirragen Advanced Wound Matrix |
| Tactile Systems Technology INC | $14.57 | 2024 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thalia Attinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.